|View printer-friendly version|
|December 10, 2004 5:23 p.m.|
|Teva Announces Tentative Approval Of Oxycodone Hydrochloride Er Tablets, 10 Mg, 20 Mg, And 40 Mg|
Jerusalem, Israel, December 10, 2004 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's ANDA for Oxycodone Hydrochloride Extended Release Tablets, 10 mg, 20 mg, and 40 mg. Final approval is subject to the expiration of any applicable exclusivity period enjoyed by another ANDA filer for the same product.